307 related articles for article (PubMed ID: 29615065)
1. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Liang B; Wu L; Xu H; Cheung CW; Fung WY; Wong SW; Wang CC
Reprod Biol Endocrinol; 2018 Apr; 16(1):32. PubMed ID: 29615065
[TBL] [Abstract][Full Text] [Related]
2. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Mizuuchi M; Moriwaka O; Kamiya H
Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410
[TBL] [Abstract][Full Text] [Related]
3. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
4. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction.
Choi J; Jo M; Lee E; Lee DY; Choi D
Mol Hum Reprod; 2020 Jan; 26(1):30-39. PubMed ID: 31814016
[TBL] [Abstract][Full Text] [Related]
5. Dienogest: a review of its use in the treatment of endometriosis.
McCormack PL
Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
7. Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
Miyashita M; Koga K; Takamura M; Izumi G; Nagai M; Harada M; Hirata T; Hirota Y; Fujii T; Osuga Y
Gynecol Endocrinol; 2014 Sep; 30(9):644-8. PubMed ID: 24805834
[TBL] [Abstract][Full Text] [Related]
8. Targeting YAP1 ameliorates progesterone resistance in endometriosis.
Lin SC; Li WN; Lin SC; Hou HT; Tsai YC; Lin TC; Wu MH; Tsai SJ
Hum Reprod; 2023 Jun; 38(6):1124-1134. PubMed ID: 37071897
[TBL] [Abstract][Full Text] [Related]
9. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
10. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
[TBL] [Abstract][Full Text] [Related]
11. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration.
Fischer OM; Kaufmann-Reiche U; Moeller C; Fuhrmann U
Gynecol Obstet Invest; 2011; 72(3):145-51. PubMed ID: 21985956
[TBL] [Abstract][Full Text] [Related]
12. Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
Saito F; Tashiro H; Yamaguchi M; Honda R; Ohba T; Suzuki A; Katabuchi H
Gynecol Endocrinol; 2016; 32(5):403-7. PubMed ID: 26680656
[TBL] [Abstract][Full Text] [Related]
13. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.
Ioffe OB; Zaino RJ; Mutter GL
Mod Pathol; 2009 Mar; 22(3):450-9. PubMed ID: 19136935
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.
Reis FM; Coutinho LM; Vannuccini S; Batteux F; Chapron C; Petraglia F
Hum Reprod Update; 2020 Jun; 26(4):565-585. PubMed ID: 32412587
[TBL] [Abstract][Full Text] [Related]
15. Dienogest in the treatment of endometriosis: systematic review.
Andres Mde P; Lopes LA; Baracat EC; Podgaec S
Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349
[TBL] [Abstract][Full Text] [Related]
16. Dienogest in the treatment of endometriosis.
Bizzarri N; Remorgida V; Leone Roberti Maggiore U; Scala C; Tafi E; Ghirardi V; Salvatore S; Candiani M; Venturini PL; Ferrero S
Expert Opin Pharmacother; 2014 Sep; 15(13):1889-902. PubMed ID: 25069386
[TBL] [Abstract][Full Text] [Related]
17. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
Mabrouk M; Paradisi R; Arena A; Del Forno S; Matteucci C; Zannoni L; Caprara G; Seracchioli R
Gynecol Endocrinol; 2018 May; 34(5):399-403. PubMed ID: 29160135
[TBL] [Abstract][Full Text] [Related]
18. The dienogest-related cystitis in women with endometriosis: a prospective, controlled, comparative study.
Krakhotkin DV; Silkina MN; Chernylovskyi VA; Gayvoronskaya SA
J Obstet Gynaecol; 2022 Aug; 42(6):2492-2497. PubMed ID: 35653789
[TBL] [Abstract][Full Text] [Related]
19. Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
Katsuki Y; Takano Y; Futamura Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
Eur J Endocrinol; 1998 Feb; 138(2):216-26. PubMed ID: 9506869
[TBL] [Abstract][Full Text] [Related]
20. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S
J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
